Results 31 to 40 of about 29,473,219 (216)

Neurofibromatosis segmentaria, a propósito de un caso

open access: yes, 2022
Introduction: neurofibromatosis is a genetic disorder that affects the growth of neural tissues, with an incidence of 1 in 4 000, with impact on life expectancy due its association with neoplasms and vascular disease.
Dufflart Ocampo, Juan David   +5 more
core   +1 more source

Mechanisms of hearing loss in neurofibromatosis type 2. [PDF]

open access: yesPLoS ONE, 2012
Patients with neurofibromatosis type 2 (NF2) develop bilateral cochleovestibular schwannomas (CVSs) that cause binaural deafness in most individuals. Hearing loss occurs in an unpredictable manner and the underlying mechanisms are not known.
Ashok R Asthagiri   +9 more
doaj   +1 more source

NEUROFIBROMATOSIS TYPE 2

open access: yesInternational Journal of Clinical Practice, 2003
SUMMARYNeurofibromatosis type 2 (NF2) is often not recognised as a distinct entity from peripheral neurofibromatosis. NF2 is a predominantly intracranial condition whose hallmark is bilateral vestibular schwannomas. NF2 results from a mutation in the gene named merlin, located on chromosome 22.
S, Uppal, A P, Coatesworth
openaire   +2 more sources

Neurofibromatosis: Types 1 and 2 [PDF]

open access: yesAmerican Journal of Neuroradiology, 2013
Neurofibromatosis types 1 and 2 are a group of neurocutaneous syndromes resulting from disorders in cell regulation. Despite sharing a common name, neurofibromatosis types 1 and 2 are quite distinct phakomatoses, both clinically and genetically.
S, Borofsky, L M, Levy
openaire   +2 more sources

A case of familial neurofibromatosis in pediatric practice

open access: yesAlʹmanah Kliničeskoj Mediciny, 2018
The article describes a  clinical case of familial neurofibromatosis. Neurofibromatosis type  1 was diagnosed in a 9-year old patient according to diagnostic criteria by the International Expert Committee on Neurofibromatosis, based on two criteria: 2 or
N. I. Zryachkin   +3 more
doaj   +1 more source

A novel NF2 splicing mutant causes neurofibromatosis type 2 via liquid-liquid phase separation with large tumor suppressor and Hippo pathway

open access: yesiScience, 2022
Summary: Neurofibromatosis type 2 is an autosomal dominant multiple neoplasia syndrome and is usually caused by mutations in the neurofibromin 2 (NF2) gene, which encodes a tumor suppressor and initiates the Hippo pathway. However, the mechanism by which
Zexiao Jia   +18 more
doaj   +1 more source

Complete pain relief after bevacizumab in a patient with neurofibromatosis type 2 [PDF]

open access: yes, 2015
Complete pain relief after bevacizumab in a patient with neurofibromatosis type
Attila Kollár (837642)   +7 more
core   +1 more source

Active Middle Ear Implant in a Patient with Neurofibromatosis Type 1 and Multiple Calvarial Defects: A Case Report

open access: yes, 2022
Bony abnormalities, including sphenoid dysplasia and calvarial defects, are well recognized in patients with neurofibromatosis type 1. However, having multiple calvarial defects is rare.
Nakamura, Takeshi   +9 more
core   +1 more source

Anesthetic consideration in a preeclamptic parturient with Von Recklinghausen′s neurofibromatosis

open access: yesJournal of Obstetric Anaesthesia and Critical Care, 2014
Neurofibromatosis is a multisystem genetic disorder that is associated with cutaneous, neurologic and orthopedic manifestations. Type 1 neurofibromatosis is characterized by dermatological lesions, such as benign neurofibromas of the skin and cafι-au ...
Tarandeep Singh   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy